Topcon and strategic investment in OKKO Health

Topcon Healthcare, Inc., a global leader in ophthalmic medical devices and digital health solutions has moved forward with a strategic investment in OKKO Health, a UK-based software medical device company. 

Topcon Healthcare played a lead role in seed funding for OKKO Health, underscoring a shared commitment to transform eyecare by empowering patients to monitor their vision from home and fostering more timely, proactive engagement with care teams.
OKKO Health’s home vision monitoring platform is designed for use on a patient’s personal smartphone, with no need for external hardware. It combines advanced vision science, data analytics, and gamified user experiences to support ongoing patient self-monitoring between clinic visits. The platform empowers patients to protect their eye health by enabling early detection of subtle changes in visual function and facilitating timely re-engagement with eye care providers when clinical intervention may be needed.
For patients with macular diseases and other chronic eye conditions, OKKO Health provides reassurance between in-office treatments and supports care models shaped by longer-acting injectable and implantable therapeutics. By giving patients an accessible, easy-to-use tool to stay connected with their vision health, OKKO Health enhances outcomes and supports clinic efficiency while helping eye care providers identify patients who require timely evaluation.